Exposure to CB-153 and p,p′-DDE and bone mineral density and bone metabolism markers in middle-aged and elderly men and women

Osteoporosis International

Volumn 16, Issue 12, 2005, Pages 2085-2094

  Wallin, Ewa ^a   Rylander, Lars ^a   Jönssson, Bo A G ^a   Lundh, Thomas ^a   Isaksson, Anders ^a   Hagmar, Lars ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bone mineral density; CrossLaps; DDE; Fish consumption; Osteocalcin; PCB

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; 2,2',4,4',5,5' HEXACHLOROBIPHENYL; BIOLOGICAL MARKER; CADMIUM; ORGANOCHLORINE DERIVATIVE; OSTEOCALCIN;

ADULT; AGED; ARTICLE; BODY MASS; BONE DENSITY; BONE METABOLISM; CONTROLLED STUDY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOOD INTAKE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; OSTEOCLAST; OSTEOPOROSIS; PRIORITY JOURNAL; URINALYSIS;

ANIMALS; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; CADMIUM; COHORT STUDIES; COLLAGEN; DENSITOMETRY, X-RAY; DICHLORODIPHENYL DICHLOROETHYLENE; DIET; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FEMALE; FISHES; FOOD CONTAMINATION; FOREARM; HUMANS; HYDROCARBONS, CHLORINATED; MALE; MIDDLE AGED; OSTEOCALCIN; PEPTIDE FRAGMENTS; POLYCHLORINATED BIPHENYLS;

EID: 29044440207     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-005-2004-3     Document Type: Article

References (54)

1. Lind PM, Eriksen EF, Sahlin L et al. (1999) Effects of the antiestrogenic environment pollutant 3,3′,4,4′,5-pentachlorobiphenyl (PCB#126) in rat bone and uterus: diverging effects in ovariectomized and intact animals. Toxicol Appl Pharmacol 154:236-244
2. Lind PM, Larsson S, Oxlund H et al. (2000) Change of bone tissue composition and impaired bone strength in rats exposed to 3,3′,4,4′, 5-pentachlorobiphenyl (PCB-126). Toxicology 150:41-51
3. Jamsa T, Viluksela M, Tuomisto JT et al. (2001) Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on bone in two rat strains with different aryl hydrocarbon receptor structures. J Bone Miner Res 16:1812-1820
4. Miettinen HM, Pulkkinen P, Jämsä T et al. (2003) In utero and lactational TCDD exposure affects rat bone development. Organohalogen Compounds 64:274-277
5. Cripps DJ, Peters HA, Gocmen A et al (1984) Porphyria turcica due to hexachlorobenzene: a 20 to 30 year follow-up study on 204 patients. Br J Dermatol 111:413-422
6. Miller RW (1985) Congenital PCB poisoning: a reevaluation. Environ Health Perspect 60:211-214
7. Turner RT, Riggs BL, Spelsberg TC (1994) Skeletal effects of estrogen. Endocrin Rev 15:275-296
8. Slemenda CW, Longcope C, Zhou L et al. (1997) Sex steroids and bone mass in older men. J Clin Invest 100:1755-1759
9. Bonefeld-Jorgensen EC, Andersen HR, Rasmussen TH et al. (2001) Effect of highly bioaccumulated polychlorinated biphenyl congeners on estrogen and androgen receptor activity. Toxicology 158:141-153
10. Danzo BJ (1997) Environmental xenobiotics may disrupt normal endocrine function by interfering with the binding of physiological ligands to steroid receptors and binding proteins. Environ Health Perspect 105:294-301
11. Kelce WR, Stone CR, Laws SC et al. (1995) Persistent DDT metabolite p,p′-DDE is a potent androgen receptor antagonist. 375:581-585
12. Sohoni P, Sumpter JP (1998) Several environmental oestrogens are also anti-androgens. J Endocrinol 158:327-339
13. Safe S, Wormke M (2003) Inhibitory aryl hydrocarbon receptor-estrogen receptor alpha cross-talk and mechanisms of action. Chem Res Toxicol 16:807-816
14. Woodhouse AJ, Cooke GM (2004) Suppression of aromatase activity in vitro by PCBs 28 and 105 and Aroclor 1221. Toxicol Lett 152:91-100
15. Fukuzawa NH, Ohsako S, Nagano R et al. (2003) Effects of 3,3′,4,4′,5-pentachlorobiphenyl, a coplanar polychlorinated biphenyl congener, on cultured neonatal mouse testis. Toxicol In Vitro 17:259-269
16. Sonnenschein C, Soto AM (1998) An updated review of environmental estrogen and androgen mimics and antagonists. J Steroid Biochem Mol Biol 65:143-150
17. Gray LE (1998) Xenoendocrine disrupters: laboratory studies on male reproductive effects. Toxicol Lett 102-103:331-335
18. Daston GP, Cook JC, Kavlock RJ (2003) Uncertainties for endocrine disrupters: our view on progress. Toxicol Sci 74:245-252
19. Kester MH, Bulduk S, Tibboel D, et al. (2000) Potent inhibition of estrogen sulfotransferase by hydroxylated PCB metabolites: a novel pathway explaining the estrogenic activity of PCBs. Endocrinology 141:1897-1900
20. Kester MH, Bulduk S, van Toor H, et al. (2002) Potent inhibition of estrogen sulfotransferase by hydroxylated metabolites of polyhalogenated aromatic hydrocarbons reveals alternative mechanism for estrogenic activity of endocrine disrupters. J Clin Endocrinol Metab 87:1142-1150
21. Gore AC, Wu TJ, Oung T, et al. (2002) A novel mechanism for endocrine-disrupting effects of polychlorinated biphenyls: direct effects on gonadotropin-releasing hormone neurons. J Neuroend 14:814-823
22. Birnbaum LS, Cummings AM (2002) Dioxins and endometriosis: a plausible hypothesis. Environ Health Perspect 110:15-21
23. Matsumura F (2003) On the significance of the role of cellular stress response reactions in the toxic actions of dioxin. Biochemical Pharmacology 66:527-540
24. Boyce WJ, Vessey MP (1985) Rising incidence of fracture of the proximal femur. Lancet 1:150-151
25. Gullberg B, Duppe H, Nilsson B et al. (1993) Incidence of hip fractures in Malmo, Sweden (1950-1991). Bone (Suppl):s23-s29
26. Gullberg B, Johnell O, Kanis JA (1997) World-wide projections for hip fracture. Osteoporos Int 7:407-413
27. Ismail AA, Pye SR, Cockerill WC et al. (2002) Incidence of Limb Fracture across Europe: Results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int 13:565-571
28. Lips P (1997) Epidemiology and predictors of fractures associated with osteoporosis. Am J Med 103:3-8
29. Kido T, Nogawa K, Yamada Y et al. (1989) Osteopenia in inhabitants with renal dysfunction induced by exposure to environmental cadmium. Int Arch Occup Environ Health 61:271-276
30. Kjellstrom T (1992) Mechanisms and epidemiology of bone effects of cadmium [review]. IARC Sci Publ 118:301-310
31. Jarup L, Alfven T, Persson B et al. (1998) Cadmium may be a risk factor for osteoporosis. Occup Environ Med 55:435-439
32. Staessen JA, Roels HA, Emlianov D et al. (1999) Environmental exposure to cadmium, forearm bone density, and risk of fractures: prospective population study. Lancet 353:1140-1144
33. Alfven T, Elinder C-G, Carlsson MD et al. (2000) Low-level cadmium exposure and osteoporosis. J Bone Miner Res 15:1579-1586.
34. Glynn AW, Michaelsson K, Lind PM et al. (2000) Organochlorines and bone mineral density in Swedish men from the general population. Osteoporosis Int 11:1036-1042
35. Beard J, Marshall S, Jong K et al. (2000) 1,1,1-trichloro-2,2-bis(p- chlorophenyl)ethane and reduced bone mineral density. Arch Environ Health 55:177-180
36. Bohannaon AD, Cooper GS, Wolff MS et al. (2000) Exposure to 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (DDT) in relation to bone mineral density and rate of bone loss in menopausal women. Arch Environ Health 55:386-391
37. Svensson BG, Nilsson A, Hansson M et al. (1991) Exposure to dioxins and dibenzofurans through the consumption of fish. N Engl J Med 324:8-12
38. Svensson BG, Nilsson A, Jonsson E et al. (1995) Fish consumption and exposure to persistent organochlorine compounds, mercury, selenium and methylamines among Swedish fishermen. Scand J Work Environ Health 21:96-105
39. Rylander L, Hagmar L (1995) Mortality and cancer incidence among women with a high consumption of fatty fish contaminated with persistent organochlorine compounds. Scand J Work Environ Health 21:419-426
40. Rylander L, Dyremark E, Strömberg U et al. (1997) The impact of age, lactation and dietary habits on PCB in plasma in Swedish women. Sci Total Environ 207:55-61
41. Alveblom A-K, Rylander L, Johnell O et al. (2003) Incidence of hospitalized osteoporotic fractures in cohorts with high dietary intake of persistent organochlorine compounds. Int Arch Occup Environ Health 76:246-248
42. Wallin E, Rylander L, Hagmar L (2004) Dietary exposure to persistent organochlorine compounds through fish consumption and incidence of osteoporotic fractures. Scand J Work Environ Health 20:30-35
43. Grimvall E, Rylander L, Nilsson-Ehle P et al. (1997) Monitoring of polychlorinated biphenyls in human blood plasma with respect to age, lactation and fish consumption; methodology developments. Arch Environ Contam Toxicol 32:329-336
44. Glynn AW, Wolk A, Aune M et al. (2000) Serum concentrations of organochlorines in men: a search for markers of exposure. Sci Total Environ 263:197-208
45. Gladen BC, Longnecker MP, Schecter AJ (1999) Correlations among polychlorinated biphenyls, dioxins, and furans in humans. Am J Ind Med 35:15-20
46. Sjödin A, Hagmar L, Klasson-Wehler E et al. (2000) Influence of the consumption of fatty Baltic Sea fish on plasma levels of halogenated environmental contaminants in Latvian and Swedish men. Environ Health Perspect 108:1035-1041
47. Richthoff J, Rylander L, Jonsson BA et al. (2003) Serum levels of 2,2,4,4,5,5 -hexachlorobiphenyl (CB-153) in relation to markers of reproductive function in young males from the general Swedish population. Environ Health Perspect 111:409-413
48. Rignell-Hydbom A, Rylander R, Giwercman A et al. (2004) Exposure to CB-153 and p,p′-DDE and male reproductive function. Hum Reprod 19:2066-2075
49. Rylander L, Nilsson-Ehle P, Hagmar L (2005) A simplified precise method for adjusting serum levels of persistent organohalogen pollutants to total serum lipids. Chemosphere (7 July; Epub ahead of print)
50. Mazzachi BC, Peake MJ, Ehrhardt V (2000) Reference range and method comparison studies for enzymatic and Jaffe creatinine assays in plasma and serum and early morning urine. Clin Lab 46:53-55
51. Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone density predict occurrence of osteopo-rotic fractures. BMJ 312:1254-1259
52. Wolff MS, Anderson HA (1999) Correspondence re: J. M. Schildkraut et al., Environmental contaminants and body fat distribution. Cancer Epidemiol Biomark Prev., 8:179-183.
53. Cancer Epidemiol Biomark Prev 8:951-952
54. Lind PM, Bergman A, Olsson M et al. (2003) BMD in male Baltic grey seal. Ambio 32:385-388